Search research articles
Contact Us
Filters
Showing results (31-40 of 94) with videos related to
Page
of 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 31, 2000
A limited sampling strategy for determining carboplatin AUC and monitoring drug dosage
E Chatelut, X Pivot, J Otto, et al.
British Journal of Cancer
|
February 18, 2010
Population pharmacokinetics of the humanised monoclonal antibody, HuHMFG1 (AS1402), derived from a phase I study on breast cancer
B Royer, W Yin, M Pegram, et al.
Head & Neck
|
July 10, 2001
Concomitant twice-a-day radiotherapy and chemotherapy in unresectable head and neck cancer patients: A long-term quality of life analysis
N Magné, P Y Marcy, E Chamorey, et al.
Cancer Causes & Control : CCC
|
March 31, 2015
Prostate cancer screening: contrasting trends
F Eisinger, J F Morère, C Touboul, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 26, 2008
A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients
X Pivot, P Koralewski, J L Hidalgo, et al.
Oncology
|
September 10, 1998
First-line vinorelbine-mitoxantrone combination in metastatic breast cancer patients relapsing after an adjuvant anthracycline regimen: results of a phase II study
A Llombart-Cussac, X Pivot, A Rhor-Alvarado, et al.
Bulletin Du Cancer
|
March 1, 1995
[Combination of mitoxantrone-vinorelbine as first-line chemotherapy for metastatic breast carcinoma]
J M Ferrero, X Pivot, M Namer, et al.
ESMO Open
|
August 9, 2021
Real-world clinical profile, treatment patterns and patient-reported outcomes in a subset of HR+/HER2- advanced breast cancer patients with poor prognostic factors: data from an international study
A Davie, G Cuyun Carter, A Rider, et al.
Gynecologie, Obstetrique, Fertilite & Senologie
|
January 5, 2021
[Overall survival and survival without local recurrence in case of radiotherapy of the tumor bed of ductal carcinomas in situ of the breast: Review of the literature]
L Kuntz, C Le Fèvre, C Hild, et al.
Breast (Edinburgh, Scotland)
|
March 29, 2011
Phase II trial of paclitaxel and uracil--tegafur in metastatic breast cancer. TEGATAX trial
C Villanueva, L Chaigneau, A Dufresne, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 94) with videos related to
Sort By:
Page
of 10
European Journal of Cancer (Oxford, England : 1990)
|
March 31, 2000
A limited sampling strategy for determining carboplatin AUC and monitoring drug dosage
E Chatelut, X Pivot, J Otto, et al.
British Journal of Cancer
|
February 18, 2010
Population pharmacokinetics of the humanised monoclonal antibody, HuHMFG1 (AS1402), derived from a phase I study on breast cancer
B Royer, W Yin, M Pegram, et al.
Head & Neck
|
July 10, 2001
Concomitant twice-a-day radiotherapy and chemotherapy in unresectable head and neck cancer patients: A long-term quality of life analysis
N Magné, P Y Marcy, E Chamorey, et al.
Cancer Causes & Control : CCC
|
March 31, 2015
Prostate cancer screening: contrasting trends
F Eisinger, J F Morère, C Touboul, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 26, 2008
A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients
X Pivot, P Koralewski, J L Hidalgo, et al.
Oncology
|
September 10, 1998
First-line vinorelbine-mitoxantrone combination in metastatic breast cancer patients relapsing after an adjuvant anthracycline regimen: results of a phase II study
A Llombart-Cussac, X Pivot, A Rhor-Alvarado, et al.
Bulletin Du Cancer
|
March 1, 1995
[Combination of mitoxantrone-vinorelbine as first-line chemotherapy for metastatic breast carcinoma]
J M Ferrero, X Pivot, M Namer, et al.
ESMO Open
|
August 9, 2021
Real-world clinical profile, treatment patterns and patient-reported outcomes in a subset of HR+/HER2- advanced breast cancer patients with poor prognostic factors: data from an international study
A Davie, G Cuyun Carter, A Rider, et al.
Gynecologie, Obstetrique, Fertilite & Senologie
|
January 5, 2021
[Overall survival and survival without local recurrence in case of radiotherapy of the tumor bed of ductal carcinomas in situ of the breast: Review of the literature]
L Kuntz, C Le Fèvre, C Hild, et al.
Breast (Edinburgh, Scotland)
|
March 29, 2011
Phase II trial of paclitaxel and uracil--tegafur in metastatic breast cancer. TEGATAX trial
C Villanueva, L Chaigneau, A Dufresne, et al.
Page
of 10